The stock is listed on the Nasdaq Global Market

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by RxSight, Inc. of its shares of common stock for up to an aggregate amount of $50 million. The common stock is listed on the Nasdaq Global Market under the symbol “RXST.”

Based in Aliso Viejo, California, RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients with its proprietary RxSight Light Adjustable Lens system.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth LeBow and Alex Moss. Partner Frank J. Azzopardi and associates David A. Frey and Lauren Nathan provided intellectual property advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California and New York offices.